Furthermore, the proportion of FOXP3+ regulatory T cells (Tregs) from 4T1 tumor-bearing mice injected with PTX plus ZnPP was lower than that from 4T1 tumor-bearing mice treated with PTX alone (Figure 6G). This evidence concerns the gene FOXP3 and neoplasm.